Prostate Cancer | Tumor

Nubeqa Improves 3-Year Survival in Nonmetastatic Prostate Cancer

January 26th 2021

At three years, overall survival in men with nonmetastatic, castration-resistant prostate cancer treated with Nubeqa was 83% compared with 77% in those who received placebo.

Men with Prostate Cancer Experience Higher Levels of Fatigue Due to Inflammation

January 13th 2021

Men who are receiving androgen deprivation therapy treatment for prostate cancer experience higher levels of fatigue and depression when compared to men who are not receiving treatment and who have no history of cancer.

Lynparza Leads to Longer Survival in Men With Prostate Cancer

January 12th 2021

Lynparza demonstrates a significantly longer duration of survival compared Xtandi or Zytiga for men with metastatic prostate cancer, one study found.

Mediterranean Diet Adherence Lowers Disease Progression in Low-Risk Prostate Cancer

January 12th 2021

Researchers observed the benefit of adhering to a Mediterranean diet in all men, in addition to non-White men and those without diabetes.

Talking about Our Family Cancer Risk With My Son

January 9th 2021

Generations of cancer leads to the risk that must be addressed head-on, but the lessons we can take from our own family members who have had cancer is valuable to pass on.

Orgovyx to Treat Advanced Prostate Cancer in Adults Receives FDA Approval

December 18th 2020

Orgovyx is the first oral drug to treat patients with advanced prostate cancer, who were previously treated with intravenous drugs that required clinic visits.

How Theranostics Differs From the Current Prostate Cancer Treatment Options

December 1st 2020

While the current field of prostate cancer research is experiencing an era of “warp speed developments,” perhaps the most exciting option on the horizon is theranostics, according to Dr. Phillip J. Koo.

FDA Approves First PET Imaging Drug for Prostate-Specific Membrane Antigen Positive Lesions in Prostate Cancer

December 1st 2020

The radioactive diagnostic agent, Gallium 68 PSMA-11, can detect suspected prostate cancer metastasis or recurrence, providing another imaging option for these patients.

How Theranostics Could Impact the Future of Prostate Cancer Treatment

November 27th 2020

The field of theranostics is growing, and its impact could change the future of prostate cancer treatment. CURE® discusses this potential with a theranostics expert.

FDA Approves Companion Diagnostic Device FoundationOne Liquid CDx for Patients with Prostate Cancer

November 9th 2020

The FDA approved this liquid biopsy to check blood for prostate-tumor DNA that indicates the presence of genetic mutations or rearrangements. The test was also recently approved for use in patients with ovarian, non-small cell lung or breast tumors.

Understanding the Role Theranostics Plays in Treating Prostate Cancer

November 6th 2020

In an interview with CURE®, Dr. Phillip J. Koo defines what theranostics is, discusses the treatment’s potential and answers questions patients may have regarding its safety.

Man Shaves Moustache for First Time in Nearly 50 Years to Raise Prostate Cancer Awareness, HGTV Star Discusses Surviving 2 Cancers, and More

November 6th 2020

From a Canadian man shaving his moustache for the first time in nearly 50 years to participate in Movember to HGTV’s “Flip or Flop” host Tarek El Moussa discussing his journey with testicular and thyroid cancer, here’s what’s happening in the cancer landscape this week.

Al Roker Announces Prostate Cancer Diagnosis

November 6th 2020

In a candid announcement on Friday, November 6th, famed Today Show host Al Roker announced his recent prostate cancer diagnosis and prognosis.

Early Study Results Show Novel Therapy Safe, Effective in Metastatic Castration-Resistant Prostate Cancer

November 3rd 2020

Treatment with a novel immuno-oncology therapy demonstrated a manageable safety profile with preliminary efficacy in patients with metastatic castration-resistant prostate cancer.

Counting My Blessings As the Wife of a Prostate Cancer Survivor

October 31st 2020

As the wife of a prostate cancer survivor, I’m eternally grateful for Colorado’s early blood draw program that helped my husband get lifesaving treatment early.

With The Novel Coronavirus, Cancer Sort Of Slipped My Mind

October 22nd 2020

The novel coronavirus that led to the COVID-19 pandemic has been a constant fixture, not dissimilar to how cancer hangs over our lives as well.

Educated Patient® Prostate Cancer Summit: September 26, 2020

October 15th 2020

View the full CURE® Educated Patient® Summit on Prostate Cancer here!

Penis Implants, Other Devices Help Improve Quality of Life Issues in Men Following Prostate Cancer Treatment

October 15th 2020

Men may experience erectile dysfunction and incontinence after receiving treatment for prostate cancer. However, there are devices — like a penile prosthetic and artificial urinary sphincter — that can help control those side effects associated with treatment.

Exercise, Diet Can Boost Bone Health in Prostate Cancer

October 14th 2020

Prostate cancer treatment can be detrimental to bone and muscle health, but an exercise regimen and healthy eating habits can help.

The Role of Surgery in Prostate Cancer Treatment

October 12th 2020

Some patients are better suited for surgery than others. In general, patients with widespread metastatic disease are also not good candidates for surgery, particularly if their cancer has spread beyond the prostate to areas like the liver, lungs, and bones.

Breaking Down Radiation Therapy for Prostate Cancer

October 12th 2020

Active surveillance can be used for many patients with prostate cancer; however, when localized, radiation therapy is an option.

Detecting Prostate Cancer Without Overtreatment Is Difficult

October 4th 2020

Finding balance to detect and treat prostate cancer without overtreatment is important for patients.

PARP Inhibitors Will Add a Treatment Option for Men with Metastatic Prostate Cancer

October 3rd 2020

PARP inhibitors are not only expanding the field of prostate cancer but they're giving men another option for life after cancer.

Where is The Balance Between Prostate Cancer Screening and Overtreatment?

October 2nd 2020

After a recommendation against routine prostate cancer screening, rates of early disease declined while the incidence of advanced disease rose. The trend highlights the difficult balance between screening and potential overtreatment.

PARP Inhibitors Demonstrate the Value of Targeted Treatments in Prostate Cancer

October 1st 2020

Primed to knock out cells vulnerable due to DNA-repair problems, PARP inhibitors are ushering in a targeted-drug era in prostate cancer treatment.

Phase 2 Study of VERU-111 in Prostate Cancer Subgroup Completes Patient Enrollment

September 30th 2020

VERU Inc. announced it has completed enrollment of 40 men with metastatic prostate cancer who have become resistant to at least one androgen receptor targeting agent for its phase 2 study of VERU-111.

Treatments for Men Whose Prostate Cancer Has Spread and Become Resistant to Hormonal Therapy are Growing

September 29th 2020

A growing number of treatments are available to men whose prostate cancer has spread and become resistant to hormonal therapy.

Coalition to Focus on Health Disparities Black Men with Prostate Cancer Face

September 28th 2020

Forward Momentum, a coalition launched by a biopharmaceutical company and three partners, focuses on the health disparities faced by Black men with prostate cancer.

Advances in Prostate Cancer

September 28th 2020

Future Use of PARP Inhibition in Prostate Cancer

September 28th 2020